Skip to main content
Caplight Logo









BioBrain

BioBrain

Private
AustraliaEnterprise Softwarehttps://biobrain.com.au

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BioBrain operates in Enterprise Software and is based in Australia. It was founded in 2021.

BioBrain is an education technology company that provides an interactive STEM learning platform for secondary school students and teachers to master biology, chemistry, and physics.

Sector

Enterprise Software

Verticals

Vertical SaaS, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Freemium

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

BioBrain Comparables

Compare BioBrain with similar companies based on industry and business-model similarity.

No comparables are published for BioBrain. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

BioBrain Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for BioBrain. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

BioBrain Investors

Notable investors and investment history

BioBrain investors
InvestorRounds
Uluwatu CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 49% MoM.

  • Apr 23, 2026

    Monthly visitors increased 82% MoM, reaching 9.8K.

Book a demo to see all signals

For institutional investors. Book with your work email.

BioBrain Filings

Explore SEC and related filing metadata, where available.

BioBrain filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about BioBrain's valuation, stock price, and market status.

Is BioBrain a public or private company?

BioBrain is a private company.

What is the current stock price of BioBrain?

BioBrain is a private company, so its shares have no public market price. Caplight tracks BioBrain's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BioBrain worth (valuation)?

Valuation information for BioBrain is not publicly available.

Can I buy BioBrain stock?

BioBrain shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BioBrain's last funding round?

Funding round information for BioBrain is not publicly available.

Who are the main investors in BioBrain?

Key investors in BioBrain include Uluwatu Capital.

Will BioBrain IPO soon?

No public IPO plans have been announced for BioBrain.

How can I track BioBrain secondary market activity?

Caplight tracks bids, offers, and trades in BioBrain's shares on secondary markets.

Firmographic Details

HeadquartersAustralia
Employee Range5
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?